UK Markets open in 3 hrs 19 mins

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
122.23+2.54 (+2.12%)
At close: 04:00PM EDT
122.40 +0.17 (+0.14%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close119.69
Bid122.30 x 1000
Ask122.47 x 1100
Day's range120.25 - 125.16
52-week range115.61 - 397.98
Avg. volume4,864,022
Market cap49.558B
Beta (5Y monthly)1.65
PE ratio (TTM)N/A
EPS (TTM)-1.96
Earnings date02 Nov 2022 - 07 Nov 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est220.67
  • Motley Fool

    Why Moderna Stock Crushed the Market Today

    The coronavirus pandemic might, just might, be easing, but top COVID-19 vaccine maker Moderna (NASDAQ: MRNA) was ascendant on Tuesday. Shortly before market close on Monday, the Food and Drug Administration (FDA) announced it had authorized a set of Moderna's latest Spikevax COVID booster vaccine for use. Strictly speaking, that company isn't covered under Moderna's emergency use authorization (EUA) for the booster.

  • Yahoo Finance Video

    The new minimum corporate tax will hit these companies the hardest, according to expert

    University of North Carolina Kenan-Flagler Business School Associate Professor Jeffrey Hoopes joins Yahoo Finance Live to explain why the new 15% minimum corporate tax rate would hit companies like Amazon and Berkshire Hathaway the hardest.

  • Motley Fool

    Down 85%, Is There Any Hope for This Struggling Vaccine Stock?

    In the early days of the pandemic, if there was one coronavirus vaccine stock investors were betting on, it was Novavax (NASDAQ: NVAX). The biotech stock soared more than 2,700% in 2020 as it developed its vaccine candidate. In the same timeframe, Pfizer shares hardly budged.